Metered-dose inhaler add-on devices: An in vitro evaluation of the BronchoAir inhaler and several spacer devices

Journal of Aerosol Medicine: Deposition, Clearance, and Effects in the Lung

Volumn 11, Issue 3, 1998, Pages 133-142

  Steckel, Hartwig ^a   Müller, Bernd W ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

Actuator; BronchoAir; Fine particle fraction; Metered dose inhaler; Multistage liquid impinger; Spacer

Indexed keywords

BECLOMETASONE DIPROPIONATE; CROMOGLYCATE DISODIUM; FLUNISOLIDE; SALBUTAMOL; TERBUTALINE; TERBUTALINE SULFATE;

AEROSOL; ASTHMA; CONFERENCE PAPER; DEVICE; DRUG DELIVERY SYSTEM; DRUG FORMULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INHALATIONAL DRUG ADMINISTRATION; METERED DOSE INHALER; PARTICLE SIZE;

EID: 0031763594     PISSN: 08942684     EISSN: None     Source Type: Journal    
DOI: 10.1089/jam.1998.11.133     Document Type: Conference Paper

References (20)

1. Aerosol Consensus Statement. 1991. Chest. 100:1106-1109.
2. Crompton, G.K. 1982. Problems patients have using pressurized aerosol inhalers. Eur. J. Respir. Dis. 63(suppl):101-104.
3. Newman, S.P., A.R. Clark, N. Talaee, and S.W. Clarke. 1989. Pressurized aerosol deposition in the human lung with and without an "open" spacer device. Thorax. 44:706-710.
4. Newman, S.P. 1992. Proving the efficacy of aerosol add-on devices: How thorough should we be? J. Biopharm. Sci. 3:185-189.
5. Barry, P.W., and C. O'Callaghan. 1995. The optimum size and shape of spacer devices for inhalation therapy. J. Aerosol Med. 8:303-305.
6. Berg, E. 1995. In vitro properties of pressurized metered-dose inhalers with and without spacer devices. J. Aerosol Med. 8(Suppl 3):3-10.
7. Brown, P.H., G. Blundell, A.P. Greening, and G.K. Crompton. 1990. Do large volume spacer devices reduce the systemic effects of high dose inhaled corticosteroids? Thorax. 45:736-739.
8. Farrer, M., A.J. Francis, and S.J. Pearce. 1990. Morning serum cortisol concentration after 2 mg inhaled beclomethasone dipropionate in normal subjects: Effect of a 750 ml spacing device. Thorax. 45:740-742.
9. König, P. 1985. Spacer devices used with metered-dose inhalers: Breakthrough or gimmick? Chest. 88:276-284.
10. Polli, G.P., W.M. Grim, F.A. Bacher, and M.A. Yunker. 1969. Influence of formulation on aerosol particle size. J. Pharm. Sci. 58:484-486.
11. Warren, S.J., and S.J. Farr. 1995. Formulation of solution metered dose inhalers and comparison with aerosols emitted from conventional suspension systems. Int. J. Pharm, 124:195-203.
12. British Pharmacopeia Commission. British Pharmacopeia. 1993. Her Majesty's Stationery Office, London.
13. Steckel, H., and B.W. Müller. 1997. In-vitro evaluation of dry powder inhalers. I: Drug deposition of commonly used devices. Int. J. Pharm. 154:19-29.
14. Marple, V.A., and K. Willeke. 1976. Impactor design. Atmospheric Environment. 10:891-896.
15. Marple, V.A. 1978. Simulation of respirable penetration characteristics by inertial impaction. J. Aerosol Sci. 9:125-134.
16. Hinds, W.C. 1982. Aerosol Technology: Properties, Behaviour and Measurement of Airborne Particles. J. Wiley & Sons, New York.
17. Hallworth, G.W., and D.G. Westmoreland. 1987. The twin impinger: A simple device for assessing the delivery of drugs from metered-dose pressurized inhalers. J. Pharm. Pharmacol. 39:966-972.
18. Olsson, B. 1997. In-vitro testing-new approaches. Presented at the Recent Advances in Dry Powder Inhalers, Management Forum, London.
19. Holzner, P.M., and B.W. Müller. 1994. An in-vitro evaluation of various spacer devices for metered-dose inhalers using the Twin Impinger. Int. J. Pharm. 106:69-75.
20. Vidgren, M.T., T.P. Paronen, A. Kärkkäinen, and P. Karjalainen. 1987. Effect of extension devices on the drug deposition from inhalation aerosols. Int. J. Pharm. 39:107-112.